WIRED @WIRED
Defining whether a drug “works” has never been easy, a task vexed by methodological uncertainty, commercial pressures, statistical errors, or sometimes straight-out bad practices. Facing a new disease, researchers have to rethink what success even means. https://t.co/7abm5nNQ2E — PolitiTweet.org